ADP_Meivertor

By using this website I agree that I am an Eye Care/Health Care Professional and have read, understood and accepted all the terms of use as outlined in the Disclaimer & the Privacy Policy

Close this notice

Full Data Page (Products) List

Sponsored

Notes

Details

How Supplied
Waiting data.
Dosing
See PDFs on this page. See full product instructions before any use.
Formulation
Waiting data
Contact Lens Use
No, see Contra-Indications/Cautions
Indications
"ZogniQ™ may be appropriate for patients presenting with:
Eyelid inflammation and redness
Puffy peri-ocular tissue
Poor eyelid hygiene
Blocked or congested-appearing lid margins
Patients undergoing routine Dry Eye management
Patients requiring support alongside lid hygiene protocols
Cosmetic concerns around redness and uneven peri-ocular skin tone".
Contra-Indications/Cautions
ECP/HCP to read and understand all accompanying product information before first use. "As with all light-based technologies, clinicians should screen patients appropriately before treatment.
ZogniQ™ should be used with caution or avoided in patients who:
Have known photosensitivity disorders
Are taking photosensitising medications
Have active ocular infection or acute inflammatory conditions requiring medical treatment
Have active malignancy in the treatment area
Have recently undergone ocular surgery (until clinically stable)
Additional caution may be advised in patients with epilepsy triggered by light sensitivity."
Contact lenses to be removed prior to treatment, wear again as advised by ECP.
Adverse Reactions
None stated. If irritation occurs, persists or increases, ECP to discontinue use and assess pt - EDDB. If vision changes or irritation occurs, persists or increases, pt to discontinue use and consult ECP/HCP.
Legal Category
Waiting data.
Notes

1. THIS PRODUCT MUST ONLY BE ADMINISTERED TO A PATIENT BY AN APPROPRIATELY TRAINED QUALIFIED ECP.

2. ON NO ACCOUNT SHOULD THE DATA CONTAINED ON THIS PAGE BE USED AS A BASIS FOR CLINICAL DECISION MAKING/PX ADVICE  - THIS SHOULD ONLY BE DONE BY REFERENCE TO THE ORIGINAL PRESCRIBER AND/OR PRODUCT DOCUMENTATION.

3. Because products are regularly improved and change, product data and advice may occasionally change. As a result, EDDB recommends that you and your patient always read the product label and Patient Information Leaflet carefully before using any products. Please do not solely rely on the information provided on this website. Because of this, EDDB is unable to accept liability for any inaccuracies or incorrect information contained on this site.

4. REMINDER: TERMS OF USE. By using this website I agree I am an Eye Care/Health Care Professional and have read, understood and accepted all the terms of use as outlined in the Disclaimer and the Privacy Policy.

5. Waiting links to find in practices in The Dry Eye Referral Directory.

Documents

ZogniQ Clinician Leaflet v2. Mar 2026.pdf ZogniQ FAQs v.2 Mar 2026.pdf ZogniQ Guidance Notes v2. Mar 2026.pdf

Share this page

Product information

Not every product may be listed, or have full data. Every effort is being made to fill in the gaps as soon as possible. It will continue to grow in breadth and depth as data arrives and products are released, almost on a daily basis. Endeavours will be made to include information on 'retailers' drops such as Sainsbury's, Superdrug etc, so you can have data available when your patient tells you they are using Tesco Allergy Drops (Sodium Cromoglicate) and asks "can I use it with my contact lenses?". If you would like to propose products for the database, have any ideas, suggestions, would like to provide missing data or see any factual inaccuracies please email adpconsultancy@gmail.com